CCG Funding Opportunities

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

New Genomic Data Analysis Network (GDAN) Centers awarded! Learn more about the awardees and their projects below.

Past Announcements and Awards

Biospecimen Processing and Storage

The NCI published a funding opportunity announcement for two functions of the Biospecimen Core Resource (BCR). The BCR will perform biospecimen collection, processing, and storage for the expanding list of NCI-supported cancer genomic programs and collaborations. The functions of the BCR will be fulfilled by three specialized centers: The Biospecimen Processing Center (BPC), the CCG Biorepository and Archive (CBA) and the Clinical Data Center (CDC). The Clinical Data Center (CDC) will be built through an already existing NCI contract.

The BPC will receive biospecimens from Tissue Source Sites (TSSs), ensure the quality of the tissue and associated data, process the tissue to produce molecular analytes, and collaborate with the CBA and CCG’s Genomic Characterization Centers (GCCs) to support CCG’s genomic research. The CBA will provide long-term storage and archiving of biospecimens received from the BPC.

Link to the Federal Project Solicitation

CTD2 Centers

NCI's Office of Cancer Genomics, a part of the Center for Cancer Genomics, has released a new Funding Opportunity Announcement (FOA). This FOA will continue to support the program Cancer Target Discovery and Development (CTD2, pronounced cee-tee-dee-squared). CTD2 is focused on efforts that advance cancer research by bridging the knowledge gap between the volumes of data generated by comprehensive molecular characterizations and studies of the underlying etiology of cancer development, progression, and/or metastasis. Access the RFA

Generating Tumor-derived Culture Models

funding opportunity aims to generate novel human tumor-derived culture models that will be made accessible to scientists around the world.

Many cancer cell lines available today have limited utility as cancer models because they lack the complex architecture of human tissue and the genomic and associated clinical information from the original tissue. In an effort to generate improved tumor models, successful vendors will create models that more closely resemble human tissue using novel techniques such as organoids, conditionally reprogrammed cells, or others. The resulting cancer cell lines will be made available to researchers through a distributor. The original tumor and the derived models will be sequenced (under a separate contract) and this information, as well as patient-pertinent clinical data, will be available to researchers through the Genomic Data Commons to serve as valuable tools for the cancer research field.

View the funding opportunity here.

Genomic Data Analysis Network (GDAN) Centers

The National Cancer Institute (NCI) has awarded funds for three different types (Processing, Visualization, and Specialized) of Genomic Data Analysis Network (GDAN) Centers to support programs of the Center for Cancer Genomics (CCG). The awardees will support the CCG pipeline by providing the bulk of the analysis of the data generated by the Genomic Characterization Centers (GCCs) and the GDAN centers will also work closely with the Analysis Working Groups (AWGs) on each CCG project.

Find out more about the GDAN awardees and their projects:

Genomic Data Analysis Network (GDAN) Awardees

Processing Genomic Data Center
Principal Investigator Project Title Institution
Gad Getz, Ph.D. Global Infrastructure for Collaborative High-throughput Cancer Genomics Analysis Broad Institute, Inc.
Visualization Genomic Data Center
Principal Investigator Project Title Institution
Jingchun Zhu, Ph.D. Visualization hub for genomics data exploration and translational discovery University of California Santa Cruz
Specialized Genomic Data Centers
Principal Investigator Project Title Institution
Li Ding, Ph.D. Deep Discovery and Clinical Interpretation of Germline and Somatic Cancer Drivers Washington University
John N. Weinstein, M.D., Ph.D. Batch effects in molecular profiling data on cancers: detection, quantitation, interpretation, and correction MD Anderson Cancer Center
Rameen Beroukhim, M.D., Ph.D. Center for the comprehensive analysis of somatic copy-number alterations in cancer Broad Institute, Inc.
Steven John Jones, Ph.D. Integrative miRNA data analysis for clinical cancer genomics British Columbia Cancer Agency
Olivier Elemento, Ph.D. The joint WCM-NYGC Center for Functional and Clinical Interpretation of Tumor Profiles Weill Medical College of Cornell University
Paul T. Spellman, Ph.D. OHSU Center for Specialized Data Analysis as part of the GDAN Oregon Health & Science University 
Joshua Stuart, Ph.D. UCSC-Buck Specialized Genomic Data Analysis Center for the Genomic Data Analysis Network University of California Santa Cruz  
Benjamin Raphael, Ph.D. Pathway and Network Integration of Cancer Genomics and Clinical Data Princeton University
Rehan Akbani, Ph.D. Integrated analysis of protein expression data from the Reverse Phase Protein Array (RPPA) platform MD Anderson Cancer Center  
Peter W. Laird, Ph.D. Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC) Van Andel Research Institute
Katherine Hoadley, Ph.D. RNA sequencing analysis of Cancer University of North Carolina Chapel Hill
  • Updated: June 9, 2016